{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:22:20Z","timestamp":1790713340570,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.ygyno.2015.02.009","type":"journal-article","created":{"date-parts":[[2015,2,18]],"date-time":"2015-02-18T17:03:08Z","timestamp":1424278988000},"page":"223-228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":137,"title":["Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: A phase 2 study"],"prefix":"10.1016","volume":"137","clinical-trial-number":[{"clinical-trial-number":"2012-004397-26","registry":"10.18810\/euctr"},{"clinical-trial-number":"nct01809379","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Clemens B.","family":"Tempfer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Winnekendonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Solass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Horvat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urs","family":"Giger-Pabst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Zieren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guenther A.","family":"Rezniczek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Andr\u00e9","family":"Reymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ygyno.2015.02.009_bb0005","first-page":"288","article-title":"Recurrent epithelial ovarian cancer: an update on treatment","volume":"27","author":"Foley","year":"2003","journal-title":"Oncology"},{"issue":"10","key":"10.1016\/j.ygyno.2015.02.009_bb0010","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1093\/annonc\/mds203","article-title":"The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane\/platinum-based therapy","volume":"23","author":"Hanker","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2015.02.009_bb0015","first-page":"395","article-title":"Emerging treatment options for management of malignant ascites in patients with ovarian cancer","volume":"4","author":"Eskander","year":"2012","journal-title":"Int. J. Womens Health"},{"issue":"5","key":"10.1016\/j.ygyno.2015.02.009_bb0020","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1525-1438.2007.01163.x","article-title":"Intraperitoneal chemotherapy in the management of patients with advanced epithelial ovarian cancer: a critical review of the literature","volume":"18","author":"Gadducci","year":"2008","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2015.02.009_bb0025","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/jnci\/89.7.480","article-title":"Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure","volume":"89","author":"Dedrick","year":"1997","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2015.02.009_bb0030","first-page":"CD005340","article-title":"Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer","volume":"11","author":"Jaaback","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ygyno.2015.02.009_bb0035","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s004649900010","article-title":"Feasibility of therapeutic pneumoperitoneum in a large animal model using a microvaporisator","volume":"14","author":"Reymond","year":"2000","journal-title":"Surg. Endosc."},{"issue":"5","key":"10.1016\/j.ygyno.2015.02.009_bb0040","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/00001813-199607000-00016","article-title":"Effects of intra-abdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administration","volume":"7","author":"Jacquet","year":"1996","journal-title":"Anticancer Drugs"},{"issue":"1","key":"10.1016\/j.ygyno.2015.02.009_bb0045","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01.sla.0000218089.61635.5f","article-title":"High intra-abdominal pressure enhances the penetration and antitumour effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis","volume":"244","author":"Esquis","year":"2006","journal-title":"Ann. Surg."},{"issue":"7","key":"10.1016\/j.ygyno.2015.02.009_bb0050","first-page":"1849","article-title":"Intraoperative intraperitonal drug delivery using a nebulizer: rationale and pharmacokinetic results","volume":"26","author":"Solass","year":"2012","journal-title":"Surg. Endosc."},{"issue":"3","key":"10.1016\/j.ygyno.2015.02.009_bb0055","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00464-011-1964-y","article-title":"Therapeutic approach of human peritoneal carcinomatosis with Dbait in combination with capnoperitoneum: proof of concept","volume":"26","author":"Solass","year":"2012","journal-title":"Surg. Endosc."},{"issue":"2","key":"10.1016\/j.ygyno.2015.02.009_bb0060","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1245\/s10434-013-3213-1","article-title":"Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy","volume":"21","author":"Solass","year":"2014","journal-title":"Ann. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2015.02.009_bb0065","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ygyno.2013.11.022","article-title":"Activity of pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in women with recurrent, platinum-resistant ovarian cancer: preliminary clinical experience","volume":"132","author":"Tempfer","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"11","key":"10.1016\/j.ygyno.2015.02.009_bb0070","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1245\/s10434-013-3039-x","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC): occupational health and safety aspects","volume":"20","author":"Solass","year":"2013","journal-title":"Ann. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2015.02.009_bb0075","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1007\/s00261-013-0013-9","article-title":"Accuracy of MDCT in the preoperative definition of Peritoneal Cancer Index (PCI) in patients with advanced ovarian cancer who underwent peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"38","author":"Mazzei","year":"2013","journal-title":"Abdom. Imaging"},{"issue":"2","key":"10.1016\/j.ygyno.2015.02.009_bb0080","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"issue":"7","key":"10.1016\/j.ygyno.2015.02.009_bb0085","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S1701-2163(16)35322-1","article-title":"Type-specific response to neoadjuvant chemotherapy: ovarian high-grade serous carcinoma versus colorectal mucinous carcinoma","volume":"34","author":"Glaze","year":"2012","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.ygyno.2015.02.009_bb0090","article-title":"U.S. Department of Health and Human Services, National Institutes of Health","author":"Common Terminology Criteria for Adverse Events (CTCAE) version 4.0; published: May 28, 2009 (v4.03: June 14, 2010)","year":"2010","journal-title":"National Cancer Institute"},{"issue":"4","key":"10.1016\/j.ygyno.2015.02.009_bb0095","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/07347332.2014.917139","article-title":"Summarizing the fifteen scales of the EORTC QLQ-C30 questionnaire by five aggregate scales with two underlying dimensions: a literature review and an empirical study","volume":"32","author":"van der Kloot","year":"2014","journal-title":"J. Psychosoc. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815006496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815006496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T04:50:27Z","timestamp":1537851027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825815006496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0090825815006496"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.02.009","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: A phase 2 study","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}